144 related articles for article (PubMed ID: 15696394)
1. Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications.
Rodriguez JA; Li M; Yao Q; Chen C; Fisher WE
World J Surg; 2005 Mar; 29(3):297-305. PubMed ID: 15696394
[TBL] [Abstract][Full Text] [Related]
2. [Towards the identification of new markers of pancreatic cancer by gene expression analysis].
Rosty C
Bull Cancer; 2004; 91(7-8):593-8. PubMed ID: 15381449
[TBL] [Abstract][Full Text] [Related]
3. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
Argani P; Iacobuzio-Donahue C; Ryu B; Rosty C; Goggins M; Wilentz RE; Murugesan SR; Leach SD; Jaffee E; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Clin Cancer Res; 2001 Dec; 7(12):3862-8. PubMed ID: 11751476
[TBL] [Abstract][Full Text] [Related]
4. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.
Argani P; Rosty C; Reiter RE; Wilentz RE; Murugesan SR; Leach SD; Ryu B; Skinner HG; Goggins M; Jaffee EM; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Cancer Res; 2001 Jun; 61(11):4320-4. PubMed ID: 11389052
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14-3-3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obtained by endoscopic ultrasound guided fine-needle aspiration.
Dim DC; Jiang F; Qiu Q; Li T; Darwin P; Rodgers WH; Peng HQ
Diagn Cytopathol; 2014 Mar; 42(3):193-9. PubMed ID: 21538952
[TBL] [Abstract][Full Text] [Related]
6. Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration.
Chen Y; Zheng B; Robbins DH; Lewin DN; Mikhitarian K; Graham A; Rumpp L; Glenn T; Gillanders WE; Cole DJ; Lu X; Hoffman BJ; Mitas M
Int J Cancer; 2007 Apr; 120(7):1511-7. PubMed ID: 17192896
[TBL] [Abstract][Full Text] [Related]
7. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.
Crnogorac-Jurcevic T; Missiaglia E; Blaveri E; Gangeswaran R; Jones M; Terris B; Costello E; Neoptolemos JP; Lemoine NR
J Pathol; 2003 Sep; 201(1):63-74. PubMed ID: 12950018
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic and predictive markers in pancreatic adenocarcinoma. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Russo SM; Ove R; Saif MW
JOP; 2011 Mar; 12(2):92-5. PubMed ID: 21386628
[TBL] [Abstract][Full Text] [Related]
9. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
11. Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer.
Li M; Bharadwaj U; Zhang R; Zhang S; Mu H; Fisher WE; Brunicardi FC; Chen C; Yao Q
Mol Cancer Ther; 2008 Feb; 7(2):286-96. PubMed ID: 18281514
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of pancreatic cancer and stromal desmoplasia.
Crnogorac-Jurcevic T; Efthimiou E; Capelli P; Blaveri E; Baron A; Terris B; Jones M; Tyson K; Bassi C; Scarpa A; Lemoine NR
Oncogene; 2001 Nov; 20(50):7437-46. PubMed ID: 11704875
[TBL] [Abstract][Full Text] [Related]
13. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK
Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells.
Showalter SL; Huang YH; Witkiewicz A; Costantino CL; Yeo CJ; Green JJ; Langer R; Anderson DG; Sawicki JA; Brody JR
Cancer Biol Ther; 2008 Oct; 7(10):1584-90. PubMed ID: 19039293
[TBL] [Abstract][Full Text] [Related]
15. How can next-generation diagnostics aid pancreatic adenocarcinoma treatment?
Zhang SQ; Catenacci DV
Future Oncol; 2016 Mar; 12(5):585-8. PubMed ID: 26831761
[No Abstract] [Full Text] [Related]
16. Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression.
Liu Y; Bunston C; Hodson N; Resaul J; Sun PH; Cai S; Chen G; Gu Y; Satherley LK; Bosanquet DC; Al-Sarireh B; Tian X; Hao C; Jiang WG; Ye L
Int J Oncol; 2017 May; 50(5):1491-1500. PubMed ID: 28393239
[TBL] [Abstract][Full Text] [Related]
17. Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma.
Costache MI; Iordache S; Costache CA; Dragos E; Dragos A; Saftoiu A
J Gastrointestin Liver Dis; 2017 Mar; 26(1):51-57. PubMed ID: 28338114
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in pancreatic ductal adenocarcinoma: new diagnostic and therapeutic clues.
Seux M; Iovanna J; Dagorn JC; Dusetti NJ
Pancreatology; 2009; 9(1-2):66-72. PubMed ID: 19077456
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.
Rosty C; Ueki T; Argani P; Jansen M; Yeo CJ; Cameron JL; Hruban RH; Goggins M
Am J Pathol; 2002 Jan; 160(1):45-50. PubMed ID: 11786397
[TBL] [Abstract][Full Text] [Related]
20. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary.
Cao D; Ji H; Ronnett BM
Int J Gynecol Pathol; 2005 Jan; 24(1):67-72. PubMed ID: 15626919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
